As shown in Supplementary Table 1, CBX8 expression levels closely correlated with several clinicopathological characteristics in CRC patients, such as clinical stage (p = 0.004), T classification (p = 0.011), M classification (p = 0.003). Here, CBX8 is linked to colorectal carcinoma.